Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers

NCT02172235 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pioglitazone
DRUG: Pioglitazone - low dose
DRUG: BI 10773 - low dose
DRUG: BI 10773 - medium dose
DRUG: BI 10773 - high dose

Sponsor

Boehringer Ingelheim